AI Infrastructure Boom Is Starving Other Sectors—And That’s a Market Risk

The stock market’s obsession with AI infrastructure is creating a dangerous capital vacuum. Right now, nearly all incoming investment flows into data center buildout plays—from warehouse REITs to machinery makers like Cummins and Dover—while other industries are left to wither.

Consider healthcare. Thermo Fisher posted strong quarterly numbers, yet its stock got hammered. Danaher, a life sciences giant, has been in a prolonged slump. Abbott Labs trades in the low $90s despite being a solid medical device company. Johnson & Johnson, with a triple-A balance sheet and 18 potential blockbuster drugs, has seen its stock drop 5% after two straight excellent earnings reports.

The pattern is clear: any stock even loosely tied to pharma is punished, while anything with a data center connection is blessed. This isn’t sustainable.

What’s the fix? More IPOs from non-AI companies could help diversify capital flows. But the looming debuts of SpaceX, OpenAI, and Anthropic threaten to pull even more money out of the broader market. If OpenAI and Anthropic delay, we might get through it. But if all three launch, we could see a repeat of the 1999-2000 internet bubble, when too many IPOs killed the bull run.

This week’s earnings from Alphabet, Amazon, Meta, and Microsoft will be a critical test. If even two of them deliver, the AI trade stays in vogue. If not, we could see a painful rebalancing.

Source: CNBC